A Study of GSM-779690T in Healthy Adult Participants
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorActa Pharmaceuticals
About this trial
A Phase 1, single-centre, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a single and multiple dose regimens of GSM-779690T in healthy adults. This first-in-human study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GSM-779690T.
Eligibility criteria
Qualifiers
Healthy and aged 18-55 years.
Current Mini Mental State Examination (MMSE) score between 27 and 30 at screening.
Able to provide their own written informed consent.
Good general health with no disease expected to interfere with the study.
Disqualifiers
None
Trial design
Treatments tested in this trial
- GSM-779690T
- Placebo
Treatment groups
72 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov